Influence of adenosine on the stimulatory effect of isoprenaline and insulin on myocardial contractility in vivo

• Published in: Cardiovascular research 1991-02, Vol.25 (2), p.151-157
• Main Authors: Law, William R, Carney, Pamela J, McLane, Michael P
• Format: Article
• Language: English
• Subjects: adenosine; Adenosine - pharmacology; Animals; Biological and medical sciences; Blood Pressure - drug effects; Dogs; Female; Fundamental and applied biological sciences. Psychology; hyperinsulinaemic euglycaemic clamp technique; inotropic state; Insulin - pharmacology; Isoproterenol - pharmacology; Male; Myocardial Contraction - drug effects; Vertebrates: cardiovascular system; β adrenergic
• ISSN: 0008-6363; 1755-3245
• DOI: 10.1093/cvr/25.2.151

Study objective – In vitro investigations have indicated that adenosine can inhibit β adrenergic stimulated increases in cardiac contractility. The present study was designed to determine the ability of adenosine to inhibit isoprenaline induced increases in contractility in vivo. Adenosine has been reported to exert its inhibitory effects on contractility by inhibiting adenylate cyclase. Thus, adenosine should have no effect on positive inotropic agents that act independently of adenylate cyclase. We therefore assessed the ability of this nucleoside to inhibit the positive inotropic effect of insulin, a hormone that exerts a positive inotropic effect independently of alterations in cyclic AMP. Design – Saline or adenosine (10 μmol·mT−1) was infused into the circumflex artery at 1 ml·min−1 as a background. Isoprenaline (20 or 200 pmol·min−1) was infused into the artery during saline or adenosine infusion. The response to insulin was determined during hyperinsulinaemic euglycaemic clamp. Subjects – 16 adult mongrel dogs were anaesthetised with pentobarbitone. Five dogs were used in isoprenaline studies, and 11 dogs in insulin studies. Measurements and main results – Dogs were instrumented to obtain measurements of mean arterial blood pressure, heart rate, circumflex artery blood flow (Q), instantaneous left ventricular pressure, and posterior left ventricular wall thickness. We used the slope of the end systolic pressure-dimension relationship (Ees) as an index of myocar-dal contractility, previously shown to reflect changes in myocardial inotropic state independent of influence from afterload and preload. Left ventricular dP/dtmax was derived from left ventricular pressure with respect to time, and Ees was determined from left ventricular pressure and wall thickness. Neither adenosine, isoprenaline, nor insulin alone caused any significant changes in mean arterial pressure or heart rate. Adenosine caused a significant increase in Q. Both left ventricular dP/dtmax and Ees were significantly increased by either insulin or both doses of isoprenaline. Adenosine inhibited the increases in these indices caused by isoprenaline, but not those caused by insulin. Conclusions – Adenosine is capable of inhibiting the positive inotropic effect of isoprenaline in vivo. The results suggest that adenosine does not inhibit positive inotropic reponses that act independently of the stimulation of adenylate cyclase.